HUP0401678A3 - 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors and pharmaceutical compositions containing them - Google Patents

2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors and pharmaceutical compositions containing them

Info

Publication number: HUP0401678A3
Authority: HU; Hungary
Prior art keywords: pyridines; phenyl; amino; substituted; pharmaceutical compositions
Prior art date: 2001-10-10

Application number

HU0401678A

Other languages

English (en)

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-10

Filing date

2002-09-24

Publication date

2007-05-02

2002-09-24 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2004-12-28 Publication of HUP0401678A2 publication Critical patent/HUP0401678A2/hu

2007-05-02 Publication of HUP0401678A3 publication Critical patent/HUP0401678A3/hu

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Rheumatology (AREA)
Reproductive Health (AREA)
Hematology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Hospice & Palliative Care (AREA)
Endocrinology (AREA)
Oncology (AREA)
Psychology (AREA)
Ophthalmology & Optometry (AREA)
Immunology (AREA)
Dermatology (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)

HU0401678A 2001-10-10 2002-09-24 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors and pharmaceutical compositions containing them HUP0401678A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US32825301P	2001-10-10	2001-10-10
PCT/IB2002/003939 WO2003030993A1 (en)	2001-10-10	2002-09-24	2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors

Publications (2)

Publication Number	Publication Date
HUP0401678A2 HUP0401678A2 (hu)	2004-12-28
HUP0401678A3 true HUP0401678A3 (en)	2007-05-02

Family

ID=23280189

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0401678A HUP0401678A3 (en)	2001-10-10	2002-09-24	2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors and pharmaceutical compositions containing them

Country Status (36)

Country	Link
EP (1)	EP1434624B1 (hu)
JP (1)	JP2005506337A (hu)
KR (1)	KR20040053157A (hu)
CN (1)	CN1568207A (hu)
AP (1)	AP2004003003A0 (hu)
AR (1)	AR036763A1 (hu)
AT (1)	ATE344089T1 (hu)
BG (1)	BG108669A (hu)
BR (1)	BR0213193A (hu)
CA (1)	CA2463364A1 (hu)
CZ (1)	CZ2004450A3 (hu)
DE (1)	DE60215837T2 (hu)
DO (1)	DOP2002000467A (hu)
EA (1)	EA007074B1 (hu)
EC (1)	ECSP045055A (hu)
EE (1)	EE200400085A (hu)
ES (1)	ES2275917T3 (hu)
GT (1)	GT200200206A (hu)
HN (1)	HN2002000289A (hu)
HR (1)	HRP20040260A2 (hu)
HU (1)	HUP0401678A3 (hu)
IL (1)	IL161089A0 (hu)
IS (1)	IS7171A (hu)
MA (1)	MA27074A1 (hu)
MX (1)	MXPA04002313A (hu)
NO (1)	NO20041411L (hu)
NZ (1)	NZ531591A (hu)
OA (1)	OA12664A (hu)
PA (1)	PA8556101A1 (hu)
PE (1)	PE20030478A1 (hu)
PL (1)	PL369454A1 (hu)
SK (1)	SK1642004A3 (hu)
TN (1)	TNSN04057A1 (hu)
UY (1)	UY27476A1 (hu)
WO (1)	WO2003030993A1 (hu)
ZA (1)	ZA200401747B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030232739A1 (en) *	2001-08-15	2003-12-18	Pfizer Inc.	Pharmaceutical combinations comprising a NOS inhibitor and an NMDA receptor antagonist
JP2008545616A (ja) *	2005-02-21	2008-12-18	プロキシマジェンエルティーディー	ジスキネジーの阻害または治療
AU2011347718B2 (en) *	2010-12-24	2016-06-23	Msd Oss B.V.	N-substituted azetidine derivatives
RU2637503C1 (ru) *	2016-12-30	2017-12-05	Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский Томский государственный университет" (ТГУ, НИ ТГУ)	Способ получения n2-метилдезоксигуанозина

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997036871A1 (en) *	1996-03-29	1997-10-09	Pfizer Inc.	6-phenylpyridyl-2-amine derivatives
UA64740C2 (uk) *	1997-02-10	2004-03-15	Пфайзер Продактс Інк.	Похідні 2-амінопіридинів, фармацевтична композиція на їх основі (варіанти), спосіб лікування (варіанти), спосіб інгібування nos у ссавця та проміжні сполуки (варіанти)
KR20020010916A (ko) *	1999-05-21	2002-02-06	실버스타인 아써 에이.	Ｎｏｓ 억제제로서의 신규한 약학 혼합물

2002
- 2002-09-23 DO DO2002000467A patent/DOP2002000467A/es unknown
- 2002-09-24 AT AT02775016T patent/ATE344089T1/de not_active IP Right Cessation
- 2002-09-24 BR BR0213193-5A patent/BR0213193A/pt not_active IP Right Cessation
- 2002-09-24 EA EA200400321A patent/EA007074B1/ru not_active IP Right Cessation
- 2002-09-24 IL IL16108902A patent/IL161089A0/xx unknown
- 2002-09-24 DE DE60215837T patent/DE60215837T2/de not_active Expired - Fee Related
- 2002-09-24 NZ NZ531591A patent/NZ531591A/en unknown
- 2002-09-24 EE EEP200400085A patent/EE200400085A/xx unknown
- 2002-09-24 ES ES02775016T patent/ES2275917T3/es not_active Expired - Lifetime
- 2002-09-24 JP JP2003534022A patent/JP2005506337A/ja not_active Withdrawn
- 2002-09-24 PL PL02369454A patent/PL369454A1/xx not_active Application Discontinuation
- 2002-09-24 WO PCT/IB2002/003939 patent/WO2003030993A1/en active IP Right Grant
- 2002-09-24 CZ CZ2004450A patent/CZ2004450A3/cs unknown
- 2002-09-24 OA OA1200400093A patent/OA12664A/en unknown
- 2002-09-24 SK SK164-2004A patent/SK1642004A3/sk not_active Application Discontinuation
- 2002-09-24 KR KR10-2004-7005248A patent/KR20040053157A/ko not_active Application Discontinuation
- 2002-09-24 HU HU0401678A patent/HUP0401678A3/hu unknown
- 2002-09-24 AP APAP/P/2004/003003A patent/AP2004003003A0/en unknown
- 2002-09-24 MX MXPA04002313A patent/MXPA04002313A/es active IP Right Grant
- 2002-09-24 EP EP02775016A patent/EP1434624B1/en not_active Expired - Lifetime
- 2002-09-24 CN CNA028200675A patent/CN1568207A/zh active Pending
- 2002-09-24 CA CA002463364A patent/CA2463364A1/en not_active Abandoned
- 2002-10-04 PE PE2002000987A patent/PE20030478A1/es not_active Application Discontinuation
- 2002-10-08 UY UY27476A patent/UY27476A1/es not_active Application Discontinuation
- 2002-10-08 AR ARP020103790A patent/AR036763A1/es unknown
- 2002-10-09 HN HN2002000289A patent/HN2002000289A/es unknown
- 2002-10-10 PA PA20028556101A patent/PA8556101A1/es unknown
- 2002-10-10 GT GT200200206A patent/GT200200206A/es unknown
2004
- 2004-03-03 ZA ZA200401747A patent/ZA200401747B/en unknown
- 2004-03-04 IS IS7171A patent/IS7171A/is unknown
- 2004-03-17 HR HRP20040260 patent/HRP20040260A2/hr not_active Application Discontinuation
- 2004-04-02 NO NO20041411A patent/NO20041411L/no unknown
- 2004-04-06 BG BG108669A patent/BG108669A/xx unknown
- 2004-04-07 TN TNP2004000057A patent/TNSN04057A1/fr unknown
- 2004-04-08 MA MA27619A patent/MA27074A1/fr unknown
- 2004-04-08 EC EC2004005055A patent/ECSP045055A/es unknown

Also Published As

Publication number	Publication date
JP2005506337A (ja)	2005-03-03
IL161089A0 (en)	2004-08-31
BR0213193A (pt)	2004-08-31
CZ2004450A3 (cs)	2005-03-16
HN2002000289A (es)	2002-12-03
ATE344089T1 (de)	2006-11-15
EA200400321A1 (ru)	2004-08-26
HRP20040260A2 (en)	2004-12-31
PA8556101A1 (es)	2003-07-28
EP1434624B1 (en)	2006-11-02
ES2275917T3 (es)	2007-06-16
WO2003030993A1 (en)	2003-04-17
DOP2002000467A (es)	2003-04-15
MXPA04002313A (es)	2005-04-08
NO20041411L (no)	2004-04-02
HUP0401678A2 (hu)	2004-12-28
BG108669A (en)	2005-03-31
DE60215837T2 (de)	2007-05-16
EP1434624A1 (en)	2004-07-07
PE20030478A1 (es)	2003-06-06
EA007074B1 (ru)	2006-06-30
ECSP045055A (es)	2004-05-28
MA27074A1 (fr)	2004-12-20
TNSN04057A1 (fr)	2006-06-01
KR20040053157A (ko)	2004-06-23
IS7171A (is)	2004-03-04
ZA200401747B (en)	2005-03-03
DE60215837D1 (de)	2006-12-14
NZ531591A (en)	2006-04-28
OA12664A (en)	2006-06-19
CA2463364A1 (en)	2003-04-17
CN1568207A (zh)	2005-01-19
AP2004003003A0 (en)	2004-03-31
EE200400085A (et)	2004-08-16
GT200200206A (es)	2003-05-23
PL369454A1 (en)	2005-04-18
SK1642004A3 (sk)	2005-04-01
AR036763A1 (es)	2004-09-29
UY27476A1 (es)	2003-05-30

Publication	Publication Date	Title
IL139697A (en)	2005-12-18	Nitric oxide synthase inhibitors, pharmaceutical compositions comprising them and process for their preparation
HUP0400194A3 (en)	2004-10-28	Imidazolidindion derivatives as metalloproteinase inhibitors, their use and pharmaceutical compositions containing them
HUP0600141A3 (en)	2008-03-28	Low hygroscopic aripiprazole-anhydrate process for its preparation, pharmaceutical compositions containing it and its use
HUP0400467A3 (en)	2012-08-28	2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use
HUP0400193A3 (en)	2004-10-28	Imidazolindion derivatives as metalloproteinase inhibitors, their use and pharmaceutical compositions containing them
HUP0200347A3 (en)	2003-05-28	N-cyanomethylamides as protease inhibitors, pharmaceutical compositions containing them and their use
HUP0402264A3 (en)	2010-03-29	Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines process for preparing them, pharmaceutical compositions containing them and use thereof
IS1847B (is)	2003-02-07	Nituroxíð sýntasa latar, notkun og aðferð til framleiðslu þeirra, ásamt lyfjasamsetningum
EP1420829A4 (en)	2006-05-17	IMMUNOMODULATING COMPOSITIONS, FORMULATIONS AND METHOD FOR THEIR USE
HUP0301577A3 (en)	2006-02-28	Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors, pharmaceutical compositions containing them and their use
EP1438046A4 (en)	2004-10-20	BENZAMIDE DERIVATIVES OF THIAZOLE AND PHARMACEUTICAL COMPOSITIONS INHIBITING CELL PROLIFERATION, AND METHODS OF USE
HUP0300909A3 (en)	2004-01-28	2-guanidino-4-arylchinazolines as nhe-3 inhibitors, pharmaceutical compositions containing them and their use
HUP0402225A3 (en)	2006-01-30	Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them
HUP0103063A3 (en)	2005-06-28	Novel 2h-pyridazin-3-one derivatives, process for their preparation, their use and pharmaceutical compositions containing them
IL162185A0 (en)	2005-11-20	Phenylpropionate derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
IL154841A0 (en)	2003-10-31	2-amino-2-alkyl-5- heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
EP1272455A4 (en)	2005-07-27	HALOGENIC DERIVATIVES OF 2-AMINO-4,5 HEPTENOIC ACID, USEFUL AS INHIBITOR OF NITRIC OXIDE SYNTHASE
HUP0500024A3 (en)	2009-01-28	6-aminomorphinane derivatives, their use and pharmaceutical compositions containing them
IL161428A0 (en)	2004-09-27	Oligoamine derivatives, methods for the production thereof and pharmaceutical compositions containing the same
HUP0201730A3 (en)	2004-12-28	Thienopyrimidines as phosphodiesterase inhibitors, their use, pharmaceutical compositions containing them and process for the preparation thereof
HUP0402028A3 (en)	2008-03-28	Unsaturated 1-amino-alkylcyclohexane derivatives, pharmaceutical compositions containing them and use thereof
EP1282420A4 (en)	2004-12-29	HALOGENED 2-AMINO-3,4-HEPTENIC ACID DERIVATE NITROGEN MONOXIDE SYNTHASE INHIBITORS
HUP0303105A3 (en)	2005-05-30	Novel aminocyclohexane derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0401644A3 (en)	2008-03-28	Aminobenzoephenones, pharmaceutical compositions containing them and use thereof
AU2001282746A1 (en)	2002-02-18	Novel phenylheteroazetidines, useful as nitric oxide synthase inhibitors

Legal Events

Date	Code	Title	Description
2007-06-28	FD9A	Lapse of provisional protection due to non-payment of fees